Philips flags possible Lumify ultrasound problems that may block or delay scanning
The Dutch inspectorate IGJ has published a manufacturer field safety notice covering Philips' Lumify diagnostic ultrasound system, citing issues that could prevent or slow scanning.
The Dutch Health and Youth Care Inspectorate (IGJ) has published a warning from Philips Medical Systems Nederland BV about the Lumify Diagnostic Ultrasound System. According to the notice, Philips has identified possible problems that may prevent or delay the system's scanning functionality.
Philips Medical Systems Nederland BV is listed as both manufacturer and authorised representative. The field safety notice (FSN) is dated 26 October 2026, one day after the IGJ item's listed publication date of 25 October 2026. The source does not explain the difference. The notice is a five-page PDF of about 344 KB, available for download from the IGJ page.
The IGJ web text does not describe the specific faults, the affected software or hardware versions, the number of devices involved, or the corrective actions Philips is asking users to take. It also does not say whether any patient harm has been reported.
As general context, manufacturers must monitor their devices after they reach the market and take action where a risk to users arises. They inform users and the inspectorate of that action through a field safety notice.
What it means for your team
- Download and read the full Philips FSN PDF, because the IGJ summary gives no detail on the faults, affected units or required actions.
- Healthcare-facility customers and distributors of Lumify should check their inventory against the notice and follow Philips' instructions once confirmed.
- Quality and vigilance teams should log the notice in their field-action tracking, noting the 26 October 2026 FSN date, and check whether any related incident reports exist.
- Treat this as a notice of possible problems, not a confirmed recall classification, since the source gives no further detail.
Article written by VigiEye from the official source (IGJ). AI-assisted; check the source before acting.
Market accessCompany releaseMedicare begins paying for Lucid's EsoGuard as PAVmed's Veris nears FDA 510(k) filing
Market accessOfficialDenmark updates Voltabak eye drop supply notice, with shortage expected to run to mid-May 2027
Market accessOfficialMethergin 0.2 mg/ml injection withdrawn from Danish market, DKMA reports
Market accessOfficialDenmark updates import window for estradiol 25 microgram patches in supply failure
Market accessOfficialDKMA updates Vivelle Dot 37.5 supply notice: shortage expected to last until end of December
Market accessOfficial